Patent on beagle dogs cancelled

WASHINGTON -- In a major victory for patented beagle dogs, the Board of Regents of the University of Texas System (UT) in Austin, Texas, disclaimed "the entire remaining term of all the claims" of patent #6,444,872, which covers live beagle dogs intended for use in experiments. In February 2004, the nonprofit organizations the American Anti-Vivisection Society (AAVS) and the PatentWatch Project of the Center for Technology Assessment (CTA) filed a legal challenge urging the U.S. Patent and Trademark Office (USPTO) to cancel the beagle patent. Last week, the Patent Office agreed to reexamine the patent.

"This is a tremendous victory not just for the beagle dogs but for the 499 other animals who have been patented in the U.S.," said AAVS President Sue Leary, "The University took the only morally defensible action it could in the face of our challenge. It got the message that animals are not machines, articles of manufacture, or inventors' compositions of matter."

The patent's claims covered, among other things, "a canine model [of fungal lung infection]," and the various methods used to induce a fatal lung infection in the beagle dogs. The patent also indicated applying the methods to pigs, sheep, monkeys, or chimpanzees and, like many other patents on animals, appeared to be exclusively licensed to a private company.

"This decision, hopefully, is a first step to rescinding all patents on animals," says Andrew Kimbrell, Executive Director of CTA. "It is long past time for our government to recognize that animals are not patentable machines."

The AAVS/PatentWatch challenge represented the first time public interest organizations had requested the reexamination of a patent on an animal. New rules under which this reexamination was granted will permit AAVS and PatentWatch to appeal other similar cases all the way to the U.S. Supreme Court if necessary. Since the Patent and Trademark Office first issued a patent on an animal in 1987, it

Contact: Crystal Miller-Spiegel
American Anti-Vivisection Society

Page: 1 2

Related biology news :

1. Patented process preserves transplant tissues/organs
2. STN International launches Derwent World Patents Index First View
3. Patent issued to U-Iowa for mutant chicken pox virus
4. Patent awarded for a method to establish genetic markers
5. Northeastern Universitys Alexander Gorlov wins prestigious Edison Patent Award for helical turbine invention
6. Research Bears Fruit, And Patents
7. Researcher Awarded Patent For System To Fight Multiple Diseases
8. Ohio State Professor Receives Patent For Infectious Bursal Disease Virus Detection Kit
9. Patented Bait System May Hold Answer To Combating Formosan Termites
10. Fred Hutchinson Cancer Research Center And Targeted Genetics Announces Issuance Of Braod Patent Covering Antigen-Specific T Cell Expansion
11. Novel Two-Antibody Strategy To Fight Cancer Awarded Patent

Post Your Comments:

(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/28/2017)... 2017 The report "Video Surveillance ... Servers, Storage Devices), Software (Video Analytics, VMS), and Service ... Forecast to 2022", published by MarketsandMarkets, the market was ... projected to reach USD 75.64 Billion by 2022, at ... base year considered for the study is 2016 and ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... maternal age to IVF success. , After comparing the results from the fresh ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks ... Strategy, will speak at the TMA 2017 Annual Meeting , October ... trends in the residential home security market and how smart safety and ... Parks ... "The residential ...
(Date:10/10/2017)... ... 10, 2017 , ... The Pittcon Program Committee is pleased ... scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each ... leading conference and exposition for laboratory science, which will be held February 26-March ...
Breaking Biology Technology:
Cached News: